HEALTH PROFESSIONAL · SOURCE READING
Standard treatment options for malignant nongerminomatous ovarian GCTs
Source: Childhood Extracranial Germ Cell Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: November 5, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Standard treatment options for malignant nongerminomatous ovarian GCTs in prepubertal females include the following:
Surgery and observation (stage I following strict surgical staging guidelines).
Source links and citations
Surgery and chemotherapy (PEb) (purported stage I and stages II–IV).
Source links and citations
Standard treatment options for malignant nongerminomatous ovarian GCTs in postpubertal females include the following:
Surgery and chemotherapy (bleomycin, etoposide, and cisplatin [BEP]) (purported stage I and stages II–IV).
Standard treatment options for malignant nongerminomatous ovarian GCTs that cannot be resected initially include the following:
Biopsy followed by chemotherapy and surgery (initially unresectable tumor).
Source links and citations
Continue within this section
Preserved source evidence · Not medical advice
Triangle